Penn Medicine leads cancer treatment breakthroughs in CAR T-cell therapy
Penn Medicine is one of the first institutions to develop FDA-approved CAR T-cell therapies. This therapy is currently approved to treat leukemia, lymphoma, and multiple myeloma.


















